Hans von Celsing

Hans von Celsing

76 year
Health Technology
Finance
Health Services

Profile

Hans Henrik von Celsing is the founder of NeuroVentures Capital LLC.
Current positions include Chairman at ADAM SA, Chairman at Partner Fondkommission AB since 2013, Chairman at Oscar Properties Holding AB since 2024, and Senior Independent Non-Executive Director at Advanced Oncotherapy Plc since 2017.
Former roles include Chief Executive Officer at Plasma Surgical Ltd., Chairman at Peptonic Medical AB from 2016 to 2022, Executive Chairman at Clinical Laserthermia Systems AB from 2015 to 2024, Director at Mevion Medical Systems, Inc., Trondheim Estate AS, and Mirada Medical Ltd., Executive Director at Gelmetix Ltd., Executive Vice President at Elekta AB from 1985 to 1999, Executive Vice President at Elekta Holdings US, Inc., and Principal at Bioxydyn Ltd. Education includes undergraduate and MBAistration degrees from Harvard Business School.

Hans von Celsing active positions

CompaniesPositionStart
ADVANCED ONCOTHERAPY PLC Director/Board Member 25/01/2017
OSCAR PROPERTIES HOLDING AB Chairman 16/06/2024
Founder -
Chairman 30/09/2013
Chairman -

Former positions of Hans von Celsing

CompaniesPositionEnd
CLINICAL LASERTHERMIA SYSTEMS AB Chairman 31/12/2023
Chief Executive Officer 31/12/2006
ELEKTA AB Corporate Officer/Principal 31/12/1998
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Hans von Celsing's experience

Training of Hans von Celsing

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Finance

Electronic Technology

Health Services

Health Technology

Finance

Technology Services

Health Services

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Commercial Services

  1. Stock Market
  2. Insiders
  3. Hans von Celsing
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!